Agios Pharmaceuticals saw the highest growth of 1.49% in patent filings in May and 1.32% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.32%. GlobalData’s DataBook provides a comprehensive analysis of Agios Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Agios Pharmaceuticals has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 11% grants. The United States(US), World Intellectual Property Organization(WIPO), Australia(AU), and Israel(IL) patent Office are among the top ten patent offices where Agios Pharmaceuticals is filings its patents. Among the top granted patent authorities, Agios Pharmaceuticals has 22% of its grants in Spain(ES), 11% in United States(US) and 11% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Agios Pharmaceuticals
Patents related to rare diseases lead Agios Pharmaceuticals's portfolio
Agios Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Anemia related patents lead Agios Pharmaceuticals portfolio followed by refining, and beta thalassaemia
Agios Pharmaceuticals has highest number of patents in anemia followed by refining, beta thalassaemia, thalassemia, and acquired (autoimmune) hemolytic anemia. For anemia, nearly 10% of patents were filed and 14% of patents were granted in Q2 2024.
For comprehensive analysis of Agios Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
